William Schuyler Jones

William Schuyler Jones

Associate Professor of Medicine

I am an interventional cardiologist with a specific focus on the diagnosis and treatment of patients with cardiovascular disease. As a clinician, I see patients in the office and do coronary and peripheral vascular procedures (angiography and interventions) in the Duke Cardiac Catheterization Laboratory. I have served as the Medical Director of the cath lab at Duke since 2016. Alongside my partners in the cath lab, we collaborate with our cardiothoracic surgeons to hold Heart Team meetings each week, and we frequently are asked to address complex cardiovascular issues as a multidisciplinary team.

I also have a broad background in cardiovascular site-based research, multicenter clinical trials, clinical event classification, and observational analyses. I have helped to lead clinical trial efforts at the Duke Clinical Research Institute (DCRI) by designing and conducting studies evaluating new and existing treatments for patients with coronary artery disease and peripheral artery disease. My specific research interests include examining access to care and disparities in care for patients with peripheral artery disease and the design and conduct of pragmatic clinical trials in cardiovascular disease.

Appointments and Affiliations

  • Associate Professor of Medicine
  • Associate Professor in Population Health Sciences
  • Member of the Duke Clinical Research Institute

Contact Information

  • Office Location: 2400 Pratt Street, 7037, Durham, NC 27705
  • Office Phone: (919) 668-8917
  • Email Address: schuyler.jones@duke.edu


  • Duke University, 2005
  • Duke University, 2004
  • M.D. University of Arkansas, Little Rock, 2001

Representative Publications

  • Hsia, J; Kavanagh, ST; Hopley, CW; Baumgartner, I; Berger, JS; Fowkes, GR; Jones, WS; Mahaffey, KW; Norgren, L; Patel, MR; Rockhold, F; Blomster, J; Katona, BG; Hiatt, WR; Bonaca, MP, Impact of chronic kidney disease on hemoglobin among patients with peripheral artery disease treated with P2Y12 inhibitors: Insights from the EUCLID trial., Vascular Medicine, vol 26 no. 6 (2021), pp. 608-612 [10.1177/1358863x211017641] [abs].
  • Weissler, EH; Ford, CB; Patel, MR; Goodney, P; Clark, A; Long, C; Jones, WS, Younger patients with chronic limb threatening ischemia face more frequent amputations., American Heart Journal, vol 242 (2021), pp. 6-14 [10.1016/j.ahj.2021.08.002] [abs].
  • Vemulapalli, S; Stebbins, A; Jones, WS; Gutierrez, JA; Patel, MR; Dolor, RJ; Pellikka, PA; Alhanti, B; Hoffmann, U; Douglas, PS, Cardiovascular risk and outcomes in symptomatic patients with suspected coronary artery disease and non coronary vascular disease: A report from the PROMISE trial., American Heart Journal, vol 242 (2021), pp. 82-91 [10.1016/j.ahj.2021.07.010] [abs].
  • Salisbury, AC; Safley, DM; Kennedy, KF; Bhardwaj, B; Aronow, HD; Jones, WS; Feldman, DN; Secemsky, E; Tsai, TT; Attaran, RR; Spertus, JA, Development and validation of a predictive model for bleeding after peripheral vascular intervention: A report from the National Cardiovascular Data Registry Peripheral Vascular Interventions Registry., Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions, vol 98 no. 7 (2021), pp. 1363-1372 [10.1002/ccd.29961] [abs].
  • Samsky, MD; Mentz, RJ; Stebbins, A; Lokhnygina, Y; Aday, AW; Pagidipati, NJ; Jones, WS; Katona, BG; Patel, MR; Holman, RR; Hernandez, AF; Gutierrez, JA, Polyvascular disease and increased risk of cardiovascular events in patients with type 2 diabetes: Insights from the EXSCEL trial., Atherosclerosis, vol 338 (2021), pp. 1-6 [10.1016/j.atherosclerosis.2021.10.011] [abs].